Clinical Trials List
2025-06-01 - 2026-12-31
Phase I/II
Recruiting9
ICD-10H40.11X0
Primary open-angle glaucoma, stage unspecified
ICD-10H40.11X1
Primary open-angle glaucoma, mild stage
ICD-10H40.11X2
Primary open-angle glaucoma, moderate stage
ICD-10H40.11X3
Primary open-angle glaucoma, severe stage
ICD-10H40.11X4
Primary open-angle glaucoma, indeterminate stage
ICD-9365.11
Primary open-angle glaucoma
-
-
Sponsor
-
-
Trial scale
Taiwan Multiple Center
-
Update
2026/09/09
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 杜培寧 Division of Ophthalmology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
207 participants
-
Global
201 participants
